DUBLIN, Dec. 03, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global In Vitro Diagnostics (IVD) Market - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
In vitro diagnostics (IVD) is the technique of diagnostic test outside the human body in an artificial environment. The IVD market revenue is expected to reach $74.65 billion by 2020, from the market value of $53.32 billion in 2013, at a CAGR of 5.34% during 2014-2020. The global IVD market is segmented based on techniques, product type, usability, application, end user and geography (North America, Europe, Asia Pacific and Rest of World).
Geographically, Asia Pacific is the fastest growing region and very opportune market that would generate highest revenue by 2020. Increase in the number of chronic and infectious diseases, and technological advancements are the major driving factors for the market. Widespread knowledge of healthcare & its benefits, and cost effectiveness are some top impacting factors of the global IVD market. The stringent regulatory policies and reimbursement issues are limiting the growth of the market. Furthermore, the rising demand for technologically advanced diagnosis devices and increased spending capabilities of consumers on health care provides huge potential for IVD in Asia Pacific market.
IVD Techniques Market Analysis
Global IVD techniques market is been segmented based on immunoassays, clinical chemistry, point of care, molecular diagnostics, hematology, coagulation, microbiology and other clinical techniques. Point of care is the highest revenue-generating segment in the overall IVD techniques market. Molecular diagnostics is the fastest growing technique in the in the overall IVD techniques market due to its ability to detect the primary cause of the disease accurately
IVD Product Type Market Analysis
The product type segment is been segmented based on instruments, reagents, data management systems and services. Instruments hold the highest market share in the global IVD market followed by reagents. Reagents market is also growing at a faster pace. As it is mostly used in various equipment and play a key role in the overall diagnosis process. Rise in the usage of diagnostic devices in which reagents are required for performing diagnosis tests, is the major factor that drives the product type market.
IVD Usability Market Analysis
Usability segment is classified as disposable and reusable IVD devices. Doctors and clinicians currently prefer disposable devices, to avoid infections. Still, reusable IVD device holds the largest revenue share in the global IVD usability market. Cost effectiveness as a benefit of reusable devices is driving the growth of usability market.
IVD Applications Market Analysis
The application area is segmented based on infectious diseases, diabetes, cancer/oncology, cardiology, autoimmune diseases, nephrology, drug testing, HIV/AIDS and others. Infectious diseases generated the highest revenue for current and forecast period mainly due to rise in the incidences of infectious diseases. HIV/AIDS application market is the second largest revenue generating applications segment and would remain the second largest through 2020.
Key Topics Covered:
CHAPTER 1 INTRODUCTION
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES
CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE
CHAPTER 6 GLOBAL IVD MARKET BY USABILITY
CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION
CHAPTER 8 GLOBAL IVD MARKET BY END USERS
CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY
CHAPTER 10 COMPANY PROFILES
Companies Mentioned:
- Abbot Laboratories
- Alere Inc
- Arkray Inc
- Bayer AG
- Becton Dickinson & Company
- Biomerieux
- Dahaner Corporation
- Johnson & Johnson
- Roche Diagnostics
- Siemens
- Sysmex Corp.
For more information visit http://www.researchandmarkets.com/research/s79vz7/global_in_vitro
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
